▼ SELL
$ Value
$14K
Shares
4,737
Price
$3
Filed
May 13
Insider
Name
Cappello Joseph
Title
VP, Pharmaceutical Development
CIK
0001939198
Roles
Officer
Transaction Details
Transaction Date
2025-05-12
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
52,266
Footnotes
Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units.
Filing Info
Cappello Joseph's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-11-17 | GNLX | ▼ | $5K |
| 2025-09-01 | GNLX | D | — |
| 2025-09-01 | GNLX | A | — |
| 2025-09-01 | GNLX | D | — |
| 2025-09-01 | GNLX | A | — |
| 2025-09-01 | GNLX | D | — |
| 2025-09-01 | GNLX | A | — |
| 2025-09-01 | GNLX | D | — |
| 2025-09-01 | GNLX | A | — |
| 2025-08-27 | GNLX | A | $0 |
Other Insiders at GNLX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Yu Yong / Cappello Joseph
SVP, Clinical Development
|
— | $2K | 2026-03-24 |
|
Zindrick Thomas
President and CEO
|
— | $9K | 2026-03-24 |
| Thomas John | — | $29K | 2026-03-02 |
|
Smalling Ralph
Head of Regulatory
|
— | $1K | 2026-03-25 |